COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Piramal Pharma Solutions Corporate Brochure

28 Sep 2021

Piramal Pharma Solutions is the contract development and manufacturing (CDMO) arm of Piramal pharma Ltd with a vast network of development and manufacturing facilities located in North America, Europe and Asia. We offer a comprehensive range of services across all the phases of the drug life cycle.

High Potency API Needs

04 Dec 2017

Piramal Pharma Solutions now offers High Potency API (HPAPI) services following its acquisition of Ash Stevens, a leader in HPAPI development and cGMP manufacture with over five decades of experience.